StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report released on Saturday. The firm issued a hold rating on the medical research company’s stock. A number of other equities analysts have also weighed in on CTSO. HC Wainwright reaffirmed a neutral rating and issued a $1.00 target price on shares […]